دورية أكاديمية
EE437 Healthcare Resource Utilization and Costs in Patients with Multiple Myeloma Who Received 1 to 3 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and Exposed to (AND DISCONTINUED) Lenalidomide in the United States
| العنوان: | EE437 Healthcare Resource Utilization and Costs in Patients with Multiple Myeloma Who Received 1 to 3 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and Exposed to (AND DISCONTINUED) Lenalidomide in the United States |
|---|---|
| المؤلفون: | Jagannath, S, Joseph, N, Chinaeke, E, Crivera, C, Fu, A, Garrett, A, Shah, N |
| المصدر: | In Value in Health July 2022 25(7) Supplement:S420-S420 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2022.04.685 |